Neoadjuvant Chemotherapy in Esophageal Cancer: Single Institution Experience
محل انتشار: مجله سرطان خاورمیانه، دوره: 2، شماره: 3
سال انتشار: 1390
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 72
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_MISJ-2-3_003
تاریخ نمایه سازی: 25 آبان 1402
چکیده مقاله:
Background: Esophageal cancer is a major clinical problem that has a generally poor prognosis. As a result, there has been interest in combining surgery with neoadjuvant chemotherapy in an attempt to improve clinical outcomes. Evidence for clinical benefit from preoperative chemotherapy exists but it is not clear which patients (stage, tumor location, and histology) will benefit the most from this preoperative treatment.Methods: This study retrospectively analyzed the outcome of ۷۱ patients with operable esophageal carcinoma treated at Northamptonshire Oncology Centre, UK from January ۲۰۰۱ until July ۲۰۰۸. Patients were treated with two cycles of neoadjuvant chemotherapy followed by surgery. Data were analyzed by Kaplan-Meier plots, Cox regression modeling and chi-squared test.Results:Median patient’s age was ۶۴ years. Male patients represented ۸۳% of the cases. Of patients, ۶۳% had an ECOG performance status of ۱. Surgical resection was done for ۶۳ (۸۸.۷%) patients. Two year overall survival in this cohort was ۵.۶%. Univariate analysis identified only surgical resection to be associated with better prognosis (P<۰.۰۰۰۱). Multivariate analysis identified surgical resection (P<۰.۰۰۰۱) and pathology type (P=۰.۰۰۷) to be the significant independent prognostic factors for survival.Conclusion: In this retrospective study, survival data for operable esophageal cancer is poor despite the use of neoadjuvant chemotherapy. Lack of a dedicated upper gastrointestinal surgeon and unavailability of PET scan staging during the study period might have attributed to the poor outcome.
نویسندگان
Hany Eldeeb
Oncology Centre, Northampton General Hospital, Cliftonville, Northampton, NN۱ ۵BD, United Kingdom
Waleed Abozeed
Department of Clinical Oncology and Nuclear Medicine, Mansoura University Hospital, Mansoura, Egypt
David Hunter
Department of Surgery, Northampton General Hospital, Cliftonville, Northampton, NN۱ ۵BD, United Kingdom
Shaffi Shaikh
Department of Family and Community Medicine, College of Medicine, King Saud University, Saudi Arabia